Antipsychotic combinations for schizophrenia-Reference-Cited by-同舟云学术

Antipsychotic combinations for schizophrenia

Published:2017-06-28 Issue:10 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ortiz-Orendain Javier¹,Castiello-de Obeso Santiago²,Colunga-Lozano Luis Enrique³,Hu Yue⁴,Maayan Nicola⁵,Adams Clive E⁶

Affiliation:

1. University of Guadalajara; Centro Universitario de Ciencias de la Salud; Sierra Mojada 950 Col. Independencia Guadalajara Jalisco Mexico 44340

2. University of Guadalajara; Center for Behavior Studies and Investigations; 180 Fco. de Quevedo Col. Arcos de Vallarta Guadalajara Jalisco Mexico 44130

3. McMaster University; Departments of Health Research Methods, Evidence, and Impact and of Medicine; 1280 Main Street West Hamilton Ontario Canada L8S 4L8

4. Tianjin University of Traditional Chinese Medicine; Graduate School; 314 An Shan Xi Road Nan Kai District Tianjin China 300193

5. Cochrane; Cochrane Response; St Albans House 57-59 Haymarket London UK SW1Y 4QX

6. The University of Nottingham; Cochrane Schizophrenia Group; Institute of Mental Health Innovation Park, Triumph Road, Nottingham UK NG7 2TU

Publisher

Wiley

Subject

Pharmacology (medical)

Reference244 articles.

1. Effectiveness of switching from antipsychotic polypharmacy to monotherapy;Essock;American Journal of Psychiatry,2011

2. Effectiveness of antipsychotic polypharmacy or monotherapy: real-world study outcomes;Fricchione Parise;European Neuropsychopharmacology,2012

3. The risks and benefits of switching patients with schizophrenia or schizoaffective disorder from two to one antipsychotic medication: a randomized controlled trial;Constantine;Schizophrenia Research,2015

4. Prophylactic effects of neuroleptics in symptom-free schizophrenics: roles of dopaminergic and noradrenergic blockers;Nishikawa;Biological Psychiatry,1985

5. Barrett WW Ellsworth RB Clark LD Enniss J Study of the differential behavioral effects of reserpine, chlorpromazine, and a combination of these drugs in chronic schizophrenic patients Diseases of the Nervous System 1957 209 15

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature;Journal of Correctional Health Care;2024-06-01

2. Focus on neurodevelopmental conditions and antipsychotics prescription patterns;International Clinical Psychopharmacology;2024-05-29

3. Influencing Factors of Prepulse Inhibition Deficit in Patients with Schizophrenia and Observations on the Efficacy of Traditional Chinese Medicine;Journal of Biobased Materials and Bioenergy;2024-03-01

4. Metabolic syndrome and its relation to antipsychotic polypharmacy in schizophrenia, schizoaffective and bipolar disorders;International Clinical Psychopharmacology;2024-02-13

5. US Department of Justice Investigation of a State Psychiatric Hospital;J AM ACAD PSYCHIATRY;2023